Eileen Tanghal

Founder and General Partner , Black Opal Ventures

2022 - Current

I co-founded Black Opal Ventures with Dr, Tara Bishop . Originally started as a mechanism for investing our own personal capital in 2019, Black Opal Ventures is now a standalone venture capital fund investing in companies using technology and promoting DEI to improve health outcomes for all.

Board Member

2022

Board Advisor

2022

Angel Investor

2017

Angel investments include: * Intellihealth (Using technology to fight the obesity epidemic) * Armstrong Robotics (A robot for every home) * Goldenspear (AI Innovation Lab)

Co-Owner

2016

My husband and I are dedicated to preparing the next generation for the needs of our world. We believe knowing how to code, just like reading and writing and using Microsoft Office will be an essential skill for all workers in the future. The Coder School offers weekly code coaching sessions and classes to 8-17 year olds. Let us help you prepare your child for the future!

Senior Partner and MD, London

2017 - 2022

IQT is the non-profit strategic investor that accelerates the development and delivery of cutting-edge technologies to the CIA and other U.S. , UK and Australian Government agencies that keep our nation safe. Our work bridges the gap between the challenging technology needs of the national security agencies, the rapidly changing innovations of the startup world, and the venture community that funds those startups. IQT occupies a distinct role at the intersection of all stakeholders – our Government and Intelligence Community customers, the venture capital community, and the startup world. It is our access to and deep understanding of these diverse communities that fuel our ability to make relevant investments.

Vice President, New Business Ventures

2015 - 2017

Global Head, Applied Ventures

2008 - 2015

During my tenure , the fund had close to $200M in 50+ investments under management. As Managing Director, I oversaw a global team making hard tech investments spanning semiconductors to medical imaging, gene sequencing and synthesis. Exits include: Liquavista (acquired by Samsung), Pinebrook Imaging (acquired by AMAT), IMS Nano (acquired by Intel). and Twist Bioscience (IPO)

Investment Director, (Founding partner KSP III)

2006 - 2008

Investment Associate, Carry partner

2002 - 2006